P569: gilteritinib and quizartinib in relapsed/refractory (r/r) acute myeloblastic leukemia (aml) with flt3 mutations: a real-life effectiveness and safety study
HemaSphere(2022)
关键词
acute myeloblastic leukemia,flt3 mutations,gilteritinib,aml,real-life
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要